Why the study?
Does dazoxiben reduce cold-induced forearm vasoconstriction and platelet aggregation in healthy volunteers?
Does dazoxiben reduce cold-induced forearm vasoconstriction and platelet aggregation in healthy volunteers?
Dazoxiben prevents cold-induced forearm vasoconstriction only in individuals whose platelet aggregation is also inhibited by the drug, suggesting a correlation between platelet behavior and vascular tone.
Supports platelet-dependent vascular effects in select volunteers; hypothesis-generating for thromboxane inhibition in vasospastic disorders.
The effect of dazoxiben, a thromboxane synthetase inhibitor, on cold-induced forearm vasoconstriction was determined in two groups of human volunteers, those in whom dazoxiben abolished the platelet aggregation and release reaction induced by sodium arachidonate (group I) and those in whom it did not (group II). Dazoxiben abolished cold-induced forearm vasoconstriction in group I volunteers but not in those of group II. These results imply a correlation between platelet behaviour and cold-induced changes in vascular tone. In the group I volunteers the effect of dazoxiben on cold-induced vasoconstriction was abolished by 1800 mg of aspirin, but not by 40 mg. Since the lower dose of aspirin inhibits platelet cyclo-oxygenase but has no effect on cyclo-oxygenase in blood vessel walls, it is possible that platelets play no part in the modulation of vascular tone by dazoxiben. It is more likely that the effects of dazoxiben are confined to the vessel wall.
No takes yet. Share an insight, caveat, or question.
Cowley et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: